FEATURED EDITORIAL

GUEST CONTRIBUTORS

More From Guest Contributors

PHARMA OUTSOURCING WHITE PAPERS

Choosing The Best Sterile Dosage Form For Your Phase I  Clinical Supply Needs Choosing The Best Sterile Dosage Form For Your Phase I Clinical Supply Needs

When developing a parenteral product, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages. With careful planning and strategic foresight, these advantages can be leveraged to great effect during the development program. Read the whitepaper to learn more.

In-House Versus Outsource: A Decision-Making Guide In-House Versus Outsource: A Decision-Making Guide

Biopharmaceutical executives must consider how outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business. Here’s a step-by-step guide to help make that decision.

The 3 Cs You Should Expect From Your Pharma Service Provider

When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

A Guide To The Development Of Monoclonal Antibodies (mAb) Purification Platforms

The use of monoclonal antibodies (MAbs) and MAb conjugates as biopharmaceuticals have increased over the last decade. As a result, more cost-effective, efficient, and flexible process purification solutions are of high priority for MAb manufacturers. Increasing product titers upstream can introduce challenges in downstream purification processes. With increased MAb titers, the cell culture supernatant might contain an elevated number of impurities (e.g., aggregates) that need to be separated from the target molecule.

9 Reasons To Consider A Single-Use Fermentor

Dedicated Fermentation Technology Replacing Stainless Steel Systems in Bioprocess Markets

Managing Demand Uncertainty In Biologics Production

How starting early, building options into your process, understanding the lead times, and continuing to evaluate your strategy can reduce uncertainty in your plans.

More From OP White Papers - random

PHARMA OUTSOURCING APP NOTES & CASE STUDIES

Is Automation The Disruption Pharma R&D Needs?

Through the implementation of automation, data management, and analytical technologies, pharma has the opportunity to breathe new life into a number of areas of the biologics drug development process.

Simplifying CAPA: Seven Steps

Troubleshooting problems and attempting to identify and prevent potential problems is a typical activity for most businesses.

Automation, Modularity Allow mAb Biotech To Cut Scale-Up Time

Bio-developers are adopting more sophisticated processes, such as perfusion, to address low titer cell lines and reduce raw material costs. They’re also seeking more flexible R&D and PD capabilities.

Are You Into Biosimilars?

Biosimilars are considered to be one of the fastest growing sectors of the pharmaceutical industry.

More Pharma Outsourcing App Notes & Case Studies

ABOUT US

Outsourced Pharma provides comprehensive analysis and exclusive content from thought leaders for the advancement of global outsourcing of drug development and manufacturing. We offer readers of our website and participants of our conferences – our Outsourced Pharma community – a deeper exploration and understanding of the relationships between pharmaceutical and biotechnology organizations with their service providers, and an open channel of communication.

About Outsourced Pharma Conferences
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.

About OutsourcedPharma.com
OutsourcedPharma.com provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.

Louis Garguilo Articles

CONNECT WITH US


@OUTSOURCEDPHARM

INDUSTRY INSIGHTS

  • Is Automation The Disruption Pharma R&D Needs?
    Is Automation The Disruption Pharma R&D Needs?

    Through the implementation of automation, data management, and analytical technologies, pharma has the opportunity to breathe new life into a number of areas of the biologics drug development process.

  • Virtue Is Harmony: Using Lab Data Automation To Break Down The Silos In Pharma R&D
    Virtue Is Harmony: Using Lab Data Automation To Break Down The Silos In Pharma R&D

    In a scenario where manufacturing processes move to a continuous flow, analyzers are producing data simultaneously, necessitating real-time processing and cloud-based tools for data management.

  • Bioburden Sources You Might Have Missed
    Bioburden Sources You Might Have Missed

    A problem with traditional mAb manufacturing is that there are so many potential entry points for microbial contamination. There are, however, ways to shut the door on contamination.

  • The Upswing Of Sterile Injectables
    The Upswing Of Sterile Injectables

    The $330 bn global sterile market is expected to reach $525 bn by 2020, growing at a CAGR of 11% -with North America contributing 48% while APAC is expected to record highest CAGR of 13%.

  • Cost Savings And Speed: The Untapped Value Of A Single-Source Solution
    Cost Savings And Speed: The Untapped Value Of A Single-Source Solution

    Small and emerging companies face significant challenges in today’s market. This calls for an alternative solution to help them achieve success. One option is a single-source solution, which can eliminate the silos that can often exist in today’s outsourcing paradigm, increasing both communication and speed.

More Industry Insights

OUTSOURCING EVENTS

Cleanroom Microbiology – A Foundational Introduction July 24 - 24, 2018
1pm-2:30pm EDT, Online Training)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Using Social Media for Patient Recruitment in Clinical Trials July 26 - 26, 2018
1)
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Writing Effective 483 and Warning Letter Responses August 2 - 2, 2018
1pm-2:30pm EDT, Online Training)
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
More Industry Events